Table of Contents
Conference Papers in Medicine
Volume 2013, Article ID 891072, 4 pages
http://dx.doi.org/10.1155/2013/891072
Conference Paper

Biomarker Diagnostics in Acute Cardiac and Noncardiac Dyspnea: Is There a Role for Point-of-Care Testing?

Institute of Laboratory Medicine, HELIOS Klinikum Berlin-Buch, Schwanebecker Chaussee 50, 13125 Berlin, Germany

Received 16 January 2013; Accepted 1 April 2013

Academic Editors: A. Bellou, E. Giannitsis, M. Möckel, and J. Searle

This Conference Paper is based on a presentation given by Dirk Peetz at “Clinical Decisions in Acute Patients: ACS–POCT–Hypertension and Biomarkers” held from 19 October 2012 to 20 October 2012 in Berlin, Germany.

Copyright © 2013 Dirk Peetz. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Thygesen, J. S. Alpert, A. S. Jaffe, M. L. Simoons, and R. Bernard, “Third universal definition of myocardial infarction,” Journal of the American College of Cardiology, vol. 60, no. 16, pp. 1581–1598, 2012. View at Google Scholar
  2. A. Torbicki, A. Perrier, S. Konstantinides et al., “Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC),” European Heart Journal, vol. 29, pp. 2276–2315, 2008. View at Google Scholar
  3. J. J. McMurray, S. Adamopoulos, S. D. Anker et al., “ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC,” European Heart Journal, vol. 33, pp. 1787–1847, 2012. View at Google Scholar
  4. D. G. Fryback and J. R. Thornbury, “The efficacy of diagnostic imaging,” Medical Decision Making, vol. 11, no. 2, pp. 88–94, 1991. View at Google Scholar · View at Scopus
  5. R. Twerenbold, T. Reichlin, M. Reiter, and C. Müller, “High-sensitive cardiac troponin: friend or foe?” Swiss Medical Weekly, vol. 141, Article ID w13202, 2011. View at Google Scholar
  6. F. S. Apple, R. Ler, and M. M. Murakami, “Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population,” Clinical Chemistry, vol. 58, pp. 1574–1581, 2012. View at Google Scholar
  7. R. Body, S. Carley, G. McDowell et al., “Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay,” Journal of the American College of Cardiology, vol. 58, pp. 1332–1339, 2011. View at Google Scholar
  8. T. Reichlin, C. Schindler, B. Drexler et al., “One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T,” Archives of Internal Medicine, vol. 172, pp. 1211–1218, 2012. View at Google Scholar
  9. F. S. Apple and P. O. Collinson, “IFCC task force on clinical applications of cardiac biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays,” Clinical Chemistry, vol. 58, pp. 54–61, 2012. View at Google Scholar
  10. R. Body, S. Carley, G. McDowell et al., “Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay,” Journal of the American College of Cardiology, vol. 58, pp. 1332–1339, 2011. View at Google Scholar
  11. A. J. Singer, H. C. Thode Jr., G. B. Green et al., “The incremental benefit of a shortness-of-breath biomarker panel in emergency department patients with dyspnea,” Academic Emergency Medicine, vol. 16, no. 6, pp. 488–494, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Venge, C. Öhberg, M. Flodin, and B. Lindahl, “Early and late outcome prediction of death in the emergency room setting by point-of-care and laboratory assays of cardiac troponin I,” American Heart Journal, vol. 160, no. 5, pp. 835–841, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. van Wijk, L. Jacobs, L. W. Eurlings et al., “Troponin T measurements by high-sensitivity vs conventional assays for risk stratification in acute dyspnea,” Clinical Chemistry, vol. 58, pp. 284–292, 2012. View at Google Scholar
  14. C. J. Lindsell, D. Raab, M. Sperling, L. Jacobus, and R. J. Ryan, “A time-and-motion study of the processes required to obtain cardiac biomarker assays using both central laboratory and point-of-care testing,” Annals of Emergency Medicine, vol. 52, no. 4, p. S66, 2008. View at Google Scholar
  15. R. Bingisser, C. Cairns, M. Christ et al., “Cardiac troponin: a critical review of the case for point-of-care testing in the ED,” American Journal of Emergency Medicine, vol. 30, pp. 1639–1649, 2012. View at Google Scholar
  16. D. Gill, S. Galvin, M. Ponsford et al., “Laboratory sample turnaround times: do they cause delays in the ED?” Journal of Evaluation in Clinical Practice, vol. 18, pp. 121–127, 2012. View at Google Scholar
  17. I. R. Lazarus and W. M. Novicoff, “State of the industry 2004: six sigma enters the healthcare mainstream: six sigma proves its staying power in a crowded field of performance improvement alternatives,” in Managed Healthcare Executive, Advanstar Communications, 2004. View at Google Scholar
  18. L. L. Holland, L. L. Smith, and K. E. Blick, “Total laboratory automation can help eliminate the laboratory as a factor in emergency department length of stay,” American Journal of Clinical Pathology, vol. 125, no. 5, pp. 765–770, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Goodacre, M. Bradburn, P. Fitzgerald et al., “The RATPAC (Randomised Assessment of Treatment using Panel Assay of Cardiac markers) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department,” Health Technology Assessment, vol. 15, no. 23, pp. 1–102, 2011. View at Publisher · View at Google Scholar
  20. S. W. Goodacre, M. Bradburn, E. Cross, P. Collinson, A. Gray, and A. S. Hall, “The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department,” Heart, vol. 97, no. 3, pp. 190–196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Christodoulides, F. N. Pierre, X. Sanchez et al., “Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care,” Methodist DeBakey Cardiovascular Journal, vol. 8, pp. 6–12, 2012. View at Google Scholar